Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
CFSB Bancorp | CFSB | Sep 19, 2024 | 6.66 | +1.60 |
CG Oncology | CGON | Sep 19, 2024 | 39.11 | +5.53 |
CGI | GIB | Sep 19, 2024 | 113.83 | +0.82 |
Chain Bridge I SPAC A | CBRG | Sep 19, 2024 | 11.30 | +0.44 |
Chain Bridge I Units | CBRGU | Sep 19, 2024 | 11.24 | 0.00 |
Champion Homes | SKY | Sep 19, 2024 | 95.65 | +2.99 |
Champions Oncology | CSBR | Sep 19, 2024 | 4.89 | +14.25 |
ChampionX | CHX | Sep 19, 2024 | 30.77 | +3.15 |
Chanson International | CHSN | Sep 19, 2024 | 2.77 | +6.54 |
ChargePoint | CHPT | Sep 19, 2024 | 1.43 | -1.38 |
Charles & Colvard | CTHR | Sep 19, 2024 | 2.06 | +7.85 |
Charles River Laboratories International | CRL | Sep 19, 2024 | 209.62 | +1.71 |
Charles Schwab | SCHW | Sep 19, 2024 | 64.76 | +1.89 |
Chart Industries | GTLS | Sep 19, 2024 | 124.31 | +2.23 |
Chart Industries | GTLS-B | Sep 19, 2024 | 51.01 | +2.24 |
Charter Communications A | CHTR | Sep 19, 2024 | 331.34 | -2.44 |
Chatham Lodging Trust (REIT) A Pref | CLDT-A | Sep 19, 2024 | 23.55 | +2.35 |
Chatham Lodging Trust REIT | CLDT | Sep 19, 2024 | 9.08 | +6.70 |
Cheche Group | CCG | Sep 19, 2024 | 0.80 | +0.45 |
Check Point Software Technolgies | CHKP | Sep 19, 2024 | 191.09 | +1.11 |
Check-Cap | CHEK | Sep 19, 2024 | 1.73 | 0.00 |
Checkpoint Therapeutics | CKPT | Sep 19, 2024 | 2.43 | -1.22 |
Cheer Holding | CHR | Sep 19, 2024 | 2.48 | +1.02 |
Cheetah Mobile ADR | CMCM | Sep 19, 2024 | 3.67 | +2.23 |
Cheetah Net Supply Chain Service | CTNT | Sep 19, 2024 | 0.23 | -6.17 |
Chegg | CHGG | Sep 19, 2024 | 1.84 | +5.14 |
Chemed | CHE | Sep 19, 2024 | 585.27 | +1.32 |
Chemomab Therapeutics ADR | CMMB | Sep 19, 2024 | 1.68 | -4.55 |
Chemours | CC | Sep 19, 2024 | 19.24 | +4.11 |
Chemung Financial | CHMG | Sep 19, 2024 | 48.79 | +3.15 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.